Latest Operating Cash Flow News

Advanced Innergy Holdings saw an 84% plunge in half-year profit despite a record £116 million order backlog, driven by project timing and IPO-related costs. The company confirmed full-year guidance and is poised for growth with key acquisitions in aquaculture and subsea manufacturing.

Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.

Mainfreight reported a 2.8% revenue increase to NZ$5.38 billion for FY26, but profit before tax declined 8.5% to NZ$350.9 million, weighed down by higher overheads and regional challenges. The company declared a steady final dividend and outlined ongoing network expansion plans.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

St Barbara Limited has secured final investment decisions for its New Simberi expansion in Papua New Guinea and the Touquoy Restart in Nova Scotia, targeting a production surge exceeding 200% over the next four years.

Codan Limited is acquiring the intellectual property of US-based Adaptive Dynamics to enhance its electronic warfare and mission-critical communications capabilities, aiming to strengthen its position in next-generation defence programs.

ChemX Materials remains suspended from ASX trading since December 2024, with no exploration activity reported in Q1 2026. The company secured an unsecured $1.2 million loan facility to support its recapitalisation and operational needs.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.